San Diego, CA -- (SBWire) -- 02/14/2023 --An investigation was announced for investors in shares of Centessa Pharmaceuticals plc (NASDAQ: CNTA) concerning potential breaches of fiduciary duties by certain directors of Centessa Pharmaceuticals plc.
Investors who are current long term investors in Centessa Pharmaceuticals plc (NASDAQ: CNTA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in NASDAQ: CNTA stocks follows a lawsuit filed against Centessa Pharmaceuticals plc over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: CNTA stocks, concerns whether certain Centessa Pharmaceuticals plc directors are liable in connection with the allegations made in that lawsuit.
The plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that lixivaptan was less safe than Defendants had represented, that Defendants overstated lixivaptan's clinical and commercial prospects, that ZF874 was less safe than Defendants had represented; (iv) Defendants overstated ZF874's clinical and commercial prospects while downplaying the drug's safety issues, and that as a result, the Offering Documents and the Company's public statements between May 28, 2021 and June 1, 2022were materially false and/or misleading and failed to state information required to be stated therein.
Those who purchased shares of Centessa Pharmaceuticals plc (NASDAQ: CNTA) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Centessa Pharmaceuticals Plc (NASDAQ:CNTA) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
An investigation on behalf of investors in Centessa Pharmaceuticals plc (NASDAQ:CNTA) shares over possible breaches of fiduciary duty by certain officers and directors was announced.